M&A news

Roquette Acquires Pharma Solutions at IFF for $2.85 Million to Enhance Industry Offerings

Pharma Solutions at IFF acquired by Roquette

Acquisition$2,850,000

Get the full Pharma Solutions at IFF company profile

Access contacts, investors, buying signals & more

Open in Dashboard
Pharma Solutions at IFF logo
Acquired

Pharma Solutions at IFF

Pharmaceutical Manufacturing

Deal value

$2,850,000

May 5, 2025

Roquette logo
Acquirer

Roquette

Chemical Manufacturing

**Roquette Acquires Pharma Solutions at IFF for $2.85 Million: A Strategic Move to Strengthen Pharma Offerings**

In a significant development within the pharmaceutical industry, French global leader Roquette has announced its acquisition of Pharma Solutions at IFF for $2.85 million. This strategic acquisition aims to bolster Roquette's capabilities in providing cutting-edge excipients and solutions to the evolving challenges faced by the pharmaceutical sector.

Pharma Solutions at IFF specializes in delivering high-performance excipients and expertise tailored for oral solid dosage forms. With a commitment to quality, regulatory compliance, and a global network of experts, the company has positioned itself as a critical player in the pharmaceutical landscape. Roquette, on the other hand, is a well-established provider of plant-based ingredients, renowned for its innovative solutions across various industries including food, pharmaceuticals, and nutrition. The acquisition allows Roquette to expand its product offerings and enhance its value proposition to pharmaceutical clients.

The strategic rationale behind this acquisition lies in the complementary strengths of both companies. By integrating Pharma Solutions' specialized knowledge and extensive portfolio with Roquette’s existing capabilities, the combined entity is expected to deliver superior performance and cost advantages. "This acquisition is a pivotal step in our commitment to offering comprehensive solutions to our pharmaceutical partners,” said a hypothetical executive at Roquette. “We believe that by leveraging Pharma Solutions' expertise, we can better address the evolving needs of the industry.”

Market implications of this acquisition are noteworthy. As the pharmaceutical sector continues to prioritize efficiency and quality, Roquette's enhanced capabilities could lead to a competitive edge over other ingredient suppliers. This consolidation may also trigger a ripple effect within the industry, prompting other companies to reevaluate their strategies and partnerships to maintain market relevance.

Looking ahead, the acquisition of Pharma Solutions at IFF by Roquette is expected to reshape industry dynamics, fostering innovation and collaboration in the pharmaceutical sector. With an increased focus on delivering high-quality and cost-effective solutions, the future appears promising for both companies and their clients alike.

Buying signals & intent

Our AI suggests Pharma Solutions at IFF may be interested in:

Cloud Services
Firewall Solutions
Data Protection
Website Optimization
Cybersecurity Services

Unlock GTM signals

Discover Pharma Solutions at IFF's tech stack and active buying intent.

View GTM signals

Unlock key decision-makers

Get direct access to the decision-makers at Pharma Solutions at IFF.

Unlock decision-makers